Title:
乳癌および卵巣癌のアジュバント療法におけるドセタキセル/ドキソルビシン/シクロホスファミドの使用
Document Type and Number:
Japanese Patent JP4773719
Kind Code:
B2
Abstract:
The present invention relates to a new method of adjuvant therapy in the treatment of early breast cancer, comprising administering six cycles of docetaxel, doxorubicin and cyclophosphamide to a patient in need thereof, wherein said dosages have a marked therapeutic effect when compared to other adjuvant therapies.
More Like This:
| WO/2000/001417 | DELIVERY SYSTEM |
| WO/2015/051349 | TREATING METASTATIC CANCER WITH MICELLULAR PACLITAXEL |
| JP2019514962 | Combination therapy for cancer treatment |
Inventors:
Ishem Sakrun
Application Number:
JP2004505157A
Publication Date:
September 14, 2011
Filing Date:
May 15, 2003
Export Citation:
Assignee:
Aventis Pharma Societe Anonym
International Classes:
A61K31/337; A61K31/351; A61K31/66; A61K31/675; A61K31/704; A61P15/00; A61P35/00; A61P35/04
Other References:
Martine J P et al.,Taxanes in the adjuvant treatment of breast cancer: Why not yet?,Journal of the National Cancer Institute Monographs,2001年,No.30,pp.88-95
DI LEO A,ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY / ESMO,NL,2000年 2月,Vol.11, No.2,pp.169-175
Buzdar A U et al.,Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial,Clinical Cancer Research,2002年 5月 1日,Vol.8,pp.1073-1079
MAMOUNAS E P,ONCOLOGY,米国,1997年 6月,Vol.11, No.6, Suppl.6,pp.37-40
D'ORAZIO A I,CLINICAL BREAST CANCER,米国,2002年,Vol.3, No.2,pp.103-105
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1998年10月,Vol.25, No.5, Suppl.12,pp.27-31
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1999年 6月,Vol.26, No.3, Suppl.8,pp.47-52
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1999年 2月,Vol.26, No.1, Suppl.3,pp.10-16
NABHOLTZ JEAN-MARC,ONCOLOGY,米国,1997年 8月,Vol.11, No.8, Suppl.8,pp.48-52
IKEDA T,EUROPEAN JOURNAL OF CANCER,2000年 9月,Vol.36, Suppl.5,S78
CLINICAL BREAST CANCER,米国,2002年,Vol.3, No.1,pp.26-28
ANTON A,SEQUENTIAL TREATMENT OF DOCETAXEL PLUS DOXORUBICIN/CYCLOPHOSPHAMIDE (AC) AS FIRST-LINE ,EUROPEAN JOURNAL OF CANCER,英国,PERGAMON PRESS,2002年 3月,Vol.38,S68-69,CHEMOTHERAPY FOR METASTATIC BREAST CANCER (MBC). FINAL RESULTS AND SURVIVAL
DI LEO A,ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY / ESMO,NL,2000年 2月,Vol.11, No.2,pp.169-175
Buzdar A U et al.,Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial,Clinical Cancer Research,2002年 5月 1日,Vol.8,pp.1073-1079
MAMOUNAS E P,ONCOLOGY,米国,1997年 6月,Vol.11, No.6, Suppl.6,pp.37-40
D'ORAZIO A I,CLINICAL BREAST CANCER,米国,2002年,Vol.3, No.2,pp.103-105
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1998年10月,Vol.25, No.5, Suppl.12,pp.27-31
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1999年 6月,Vol.26, No.3, Suppl.8,pp.47-52
NABHOLTZ JEAN-MARC,SEMINARS IN ONCOLOGY,1999年 2月,Vol.26, No.1, Suppl.3,pp.10-16
NABHOLTZ JEAN-MARC,ONCOLOGY,米国,1997年 8月,Vol.11, No.8, Suppl.8,pp.48-52
IKEDA T,EUROPEAN JOURNAL OF CANCER,2000年 9月,Vol.36, Suppl.5,S78
CLINICAL BREAST CANCER,米国,2002年,Vol.3, No.1,pp.26-28
ANTON A,SEQUENTIAL TREATMENT OF DOCETAXEL PLUS DOXORUBICIN/CYCLOPHOSPHAMIDE (AC) AS FIRST-LINE ,EUROPEAN JOURNAL OF CANCER,英国,PERGAMON PRESS,2002年 3月,Vol.38,S68-69,CHEMOTHERAPY FOR METASTATIC BREAST CANCER (MBC). FINAL RESULTS AND SURVIVAL
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Shoji Miwa
Noriyuki Takebayashi